Home >  News >  March, 2011

Medtronic Buys Hemostatic Gel Technology for Use in Endoscopic Sinus Surgery

Chitosan-dextran gel could help prevent bleeding and adhesions, says medical device maker.

Published: March 1, 2011

Medtronic has acquired a hemostatic chitosan-dextran gel technology from Australian and New Zealand researchers that it plans to use to develop products for functional endoscopic sinus surgery (FESS).

Bleeding and adhesions are the most common complications from FESS. In announcing the acquisition, Medtronic says both animal and human studies have shown the chitosan-dextran gel, a polymer derived from the chitin of shellfish and squid, has rapid, powerful hemostatic properties that could help prevent these complications and improve post-operative wound healing after FESS.

The Minnesota-based medical device company's acquisition of the gel from Australia's Adelaide Research & Innovation and New Zealand's Robinson Squidgel and Otago Innovation, will "enhance Medtronic's ability to offer innovative, therapeutic products for sinus surgeons to use in post-operative patient care," said Mark Fletcher, president of Medtronic Surgical Technologies' ENT division, in a statement.

Irene Tsikitas

Also in the News...

Senator Creates Firestorm With Nurses Playing Cards Comment
Suspect Logged Into Electronic Prescription Program as Ophthalmologist to Fraudulently Issue Opioid Scripts
Marijuana Users May Need Higher Doses of Sedatives Before Endoscopy
Brainlab Recalls Spine & Trauma 3D Navigation 1.0 Software Due to Display Inaccuracies
FDA Orders Withdrawal Of Transvaginal Surgical Mesh From Market
Lawsuit: When PACU Lights Dimmed, Doc Asked Wife to Hold Penlight on Her Husband's Leaking JP Drain
R.I. Smoke Evacuation Legislation Becomes Law

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Innovations in Sinus Surgery

4 advances in opening the pathways of the sinuses and clearing blockages.